Medication info

Simvastatin Tablets (Simvastatin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 200403740 · Notified 2004.09.22

This product's status changed to Approval withdrawn on 2024.07.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk The recommended initial starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The recommended usual initial starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose as appropriate according to the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for the recommended doses in patients taking this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when administered alone or in combination with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Receive This Drug under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start treatment at 5 mg per day and monitor carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medicine helps reduce the risk of death due to coronary heart disease and the risk of non-fatal myocardial infarction and stroke in adult patients at high risk of cardiovascular diseases such as coronary heart disease, diabetes, peripheral vascular diseases, and stroke. It also reduces the risks that can occur after coronary and non-coronary vascular interventions. It is effective in the treatment of hyperlipidemia, lowering cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing good cholesterol (HDL). In pediatric patients with heterozygous familial hypercholesterolemia, it is used alongside dietary therapy to reduce LDL cholesterol and Apo-B protein levels. This drug is effective in improving cardiovascular health and managing dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk The recommended initial starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The recommended usual initial starting dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose as appropriate according to the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this drug, particularly during the first year of treatment, should be used only in patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for the recommended doses in patients taking this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Results of controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when administered alone or in combination with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Receive This Drug under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start treatment at 5 mg per day and monitor carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dosage range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day.

Precautions

This medication may cause side effects that impact muscles, particularly the risk of muscle pain or weakness increases with high doses. If you experience unexplained muscle pain, tenderness, or weakness while taking this medication, you should inform your doctor immediately. As this medication is mainly metabolized in the liver, caution should be exercised when administering it to patients with impaired liver function or a history of liver disease, and regular liver function tests are necessary. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication and must discontinue it immediately if pregnancy is confirmed. This medication may interact with certain drugs, causing increased blood concentration and elevating the risk of side effects. Therefore, if you are taking other medications, you must consult your doctor or pharmacist. Particular attention is required when taken in combination with potent CYP3A4 inhibitors, certain lipid-lowering drugs, specific antibiotics, and calcium channel blockers. Elderly patients, those with kidney or thyroid issues, and alcoholics must be monitored more carefully while taking this medication. This medication can increase blood sugar levels, so patients at risk of diabetes should regularly monitor their blood sugar. During treatment, it is advisable to avoid the intake of certain foods like grapefruit juice, and in case of overdose, you should seek immediate medical attention. This medication should only be used in children over the age of 10 under the direction of a specialist due to potential effects on growth and maturation. Lastly, this medication should be taken strictly following a doctor’s prescription and instruction, and stored out of reach of children.

Side effects

  • myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 88 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disturbances
  • extraocular movement disorders
  • facial incomplete paralysis
  • tremors
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive disorders
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • sensory numbness in the limbs
  • paresthesia
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • lupus erythematosus-like syndrome
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • erythema multiforme
  • interstitial lung disease
  • vomiting
  • mucous stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, and it is recommended to keep it at room temperature between 1°C and 30°C. Proper storage will maintain the drug's effectiveness and ensure safe use.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.